DHI vs SNDX · P/E 9.6, rev $34.25B vs rev $137.7M
DR Horton Inc (DHI) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the DHI and SNDX stock pages for the full models.
Not investment advice.